Do Allergy Shots Work? The Evidence, Limits, and Honest Verdict
Allergy shots (SCIT) produce meaningful, measurable symptom relief: a 2007 Cochrane review of 51 randomized trials found a pooled symptom reduction of SMD -0.73 — comparable to intranasal corticosteroids. Roughly 50-80% of patients achieve clinically meaningful improvement. However, 20-50% are low responders, and only 18% of patients reach the recommended 3-year minimum in real-world practice. Treatment duration of at least 3 years is the strongest predictor of lasting results.
8 peer-reviewed sources
Yes, allergy shots work for most patients — clinical trials show 50-80% achieve meaningful symptom reduction. But roughly 20-50% respond poorly, usually due to stopping too early, suboptimal allergen selection, or inadequate dosing.
The Skeptic's Question: Do Allergy Shots Actually Do Anything?
Allergy shots work — but not equally for everyone, and not without real caveats. The scientific evidence is genuine and substantial: across more than 51 randomized controlled trials enrolling nearly 3,000 patients, subcutaneous immunotherapy (SCIT) consistently outperforms placebo in reducing nasal and eye symptoms, cutting medication use, and improving quality of life. The pooled effect size (SMD -0.73 for symptoms, per Calderon et al., Cochrane 2007) places allergy shots on par with intranasal corticosteroids — the current gold standard for allergic rhinitis. Benefits are also disease-modifying, meaning the immune system changes persist years after treatment ends, not just while injections continue.
The honest counterweight: 20-50% of SCIT patients fall into a low-responder category, and in real-world practice only about 18% ever complete the recommended 3-year minimum course. These aren't failures of the underlying science — they're failures of duration, allergen selection, and dosing precision. When treatment is adequate and the right allergen is targeted, results are substantial and durable.
Before starting any immunotherapy, identifying your exact allergen triggers is the essential first step. Comprehensive allergy testing — including at-home options like Curex, which covers 40+ allergens and delivers results within a week — pinpoints the specific IgE-mediated sensitivities that determine whether SCIT is likely to work for you.
Allergy shots work for most patients who complete treatment, but adherence is the rate-limiting variable — only 18% reach the 3-year minimum required for durable disease modification.
Why Allergy Shots Change the Immune System — Not Just Symptoms
Unlike antihistamines and nasal sprays that suppress symptoms, allergy shots reprogram the immune response at its source. Each injection delivers a tiny dose of your specific allergen — just enough to trigger immune adaptation without causing a full allergic reaction. Over months and years, this graduated exposure shifts your immune system from an IgE-mediated hypersensitive response toward immune tolerance. The result is not merely symptom suppression but a measurable change in the underlying biology of your allergy.
Graded Allergen Exposure
Injections begin at doses thousands of times below the threshold that triggers symptoms. Each week, the dose increases incrementally. This slow escalation allows the immune system to encounter allergens without launching a full-scale allergic response.
IgG4 Blocking Antibodies Rise
As treatment progresses, the body produces IgG4 antibodies — sometimes called blocking antibodies — that compete with IgE for allergen binding sites. Higher IgG4 levels mean less allergen reaches mast cells and basophils, reducing histamine release and downstream symptoms.
Regulatory T-Cell Tolerance
SCIT shifts the immune response from a Th2-dominant (allergic) pattern toward regulatory T-cell activity and Th1 balance. Interleukin-10 production rises, further suppressing IgE-mediated activation. These T-cell changes underpin the long-term durability of SCIT benefits after treatment ends.
Sustained Remission After Stopping
Durham et al. (N Engl J Med, 1999) demonstrated the landmark disease-modifying finding: three years after stopping a 3-4 year grass SCIT course, symptom and medication scores remained as low as during continued maintenance — significantly lower than untreated controls. IgG4 levels persist, and clinical remission continues even as skin test reactivity partially wanes.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
How Long Until Allergy Shots Produce Results?
Allergy shots work on a slow, deliberate schedule that mirrors the immune system's pace of change. Most patients notice partial symptom improvement within 3-6 months of starting, but the full clinical benefit — and the disease modification that persists after stopping — requires a minimum of 3 years. Understanding the three phases helps set realistic expectations and, critically, supports the adherence that makes treatment work.
Injections start at a dose thousands of times below your therapeutic target and increase weekly until you reach your maintenance dose. You'll visit the clinic roughly 24-30 times during this phase, staying 30 minutes after each injection. Some patients notice early symptomatic improvement in the final weeks of buildup.
Once you reach the target allergen dose, injections continue at a stable level with decreasing frequency. Most patients receive shots monthly or every few weeks. This phase is where the sustained immunologic changes compound — IgG4 antibodies rise, regulatory T-cell tolerance deepens, and the clinical improvements become durable.
Patients who complete at least 3 years of SCIT typically experience sustained remission after stopping. Durham et al. (NEJM 1999) showed benefits persisting 3+ years post-discontinuation; Eng et al. (Allergy 2006) documented significant clinical benefit 12 years after treatment ended in pediatric patients.
What the Evidence Actually Shows: Responders vs. Non-Responders
The core finding from the largest synthesis of SCIT evidence is a moderate-to-large effect: pooled symptom SMD -0.73 (95% CI -0.97 to -0.50) across 51 randomized trials (Calderon et al., Cochrane Database Syst Rev 2007). In practical terms, Matricardi et al. (JACI 2011) calculated a 34.7% relative reduction in total nasal symptom scores versus placebo — comparable to intranasal mometasone (-31.7%) and substantially better than desloratadine (-12.0%). But the aggregate figure conceals a critical split: roughly 57% of patients are high responders and 43% are low or non-responders (Li et al., Beijing HDM cohort, 2019). The dominant reasons for non-response are inadequate treatment duration, suboptimal allergen selection, and subtherapeutic dosing — not failure of the underlying immunologic mechanism.
Success Rate by Duration
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youAllergy Shots vs. Other Treatments: What Actually Works Best?
Allergy shots are not the only option — and understanding the comparison helps patients choose based on their own circumstances. Head-to-head network meta-analyses show FDA-approved sublingual tablets achieve comparable symptom relief for grass and dust mites, while antihistamines and nasal steroids provide faster but temporary relief without disease modification. The critical difference that shots and drops share, and that pills do not: disease-modifying durability that outlasts the treatment course by years. And the shot route no longer requires weekly clinic trips — Curex delivers SCIT as an at-home kit, with the first dose and every dose change supervised live over Zoom by a board-certified allergist.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-Home Allergy Shots (SCIT) — CurexBest | SMD -0.73 symptom reduction; 50-80% of patients achieve clinically meaningful improvement | 3-5 years total | $3,000-$15,000 | Self-administered at home with Curex: weekly build-up for 3-6 months, then monthly; first dose and dose changes supervised live over Zoom, with a brief self-observation after each — no weekly clinic visits | Systemic reactions in 0.1% of visits; very rare anaphylaxis (~1 per 2.5M injections) |
Sublingual Drops (SLIT) | Comparable efficacy to SCIT for major allergens per Nelson network meta-analysis 2015 | 3-5 years total | $2,340-$12,000 | Daily drops taken at home; no clinic visits after initial evaluation | Zero documented fatalities worldwide; local oral reactions common but mild |
Antihistamines (OTC) | Symptom reduction ~12% relative to placebo (Matricardi 2011); no disease modification | Continuous — symptoms return when stopped | $350-$3,500 | Daily pill; no clinic visits required | Generally very safe; non-sedating second-generation options preferred |
Nasal Corticosteroids | ~31.7% TNSS reduction; strongest symptom control of all pharmacotherapy options | Continuous — symptoms return when stopped | $500-$2,000 | Daily nasal spray; no clinic visits required | Minimal systemic absorption; mild local effects (dryness, epistaxis) |
- Efficacy
- SMD -0.73 symptom reduction; 50-80% of patients achieve clinically meaningful improvement
- Duration
- 3-5 years total
- Cost (5yr)
- $3,000-$15,000
- Convenience
- Self-administered at home with Curex: weekly build-up for 3-6 months, then monthly; first dose and dose changes supervised live over Zoom, with a brief self-observation after each — no weekly clinic visits
- Safety
- Systemic reactions in 0.1% of visits; very rare anaphylaxis (~1 per 2.5M injections)
- Efficacy
- Comparable efficacy to SCIT for major allergens per Nelson network meta-analysis 2015
- Duration
- 3-5 years total
- Cost (5yr)
- $2,340-$12,000
- Convenience
- Daily drops taken at home; no clinic visits after initial evaluation
- Safety
- Zero documented fatalities worldwide; local oral reactions common but mild
- Efficacy
- Symptom reduction ~12% relative to placebo (Matricardi 2011); no disease modification
- Duration
- Continuous — symptoms return when stopped
- Cost (5yr)
- $350-$3,500
- Convenience
- Daily pill; no clinic visits required
- Safety
- Generally very safe; non-sedating second-generation options preferred
- Efficacy
- ~31.7% TNSS reduction; strongest symptom control of all pharmacotherapy options
- Duration
- Continuous — symptoms return when stopped
- Cost (5yr)
- $500-$2,000
- Convenience
- Daily nasal spray; no clinic visits required
- Safety
- Minimal systemic absorption; mild local effects (dryness, epistaxis)
For patients who want immunotherapy's disease-modifying benefits without weekly clinic visits, Curex delivers the shot route itself as an at-home allergy shot kit (SCIT) — $129/month all-inclusive, with a personalized serum sterile-compounded to USP <797>, one weekly shot you give yourself at home, and your first dose and every dose change supervised live over Zoom by a board-certified allergist after a prescribed epinephrine auto-injector is confirmed on hand. It addresses the same underlying allergen triggers as a traditional clinic shot course.
See if at-home shots are right for youWhat Can Go Wrong — and How Rare Is It Really?
Allergy shots carry a well-characterized safety profile: local injection-site reactions are very common and normal; systemic reactions affect roughly 0.1% of injection visits; anaphylaxis requiring epinephrine is very rare; and fatal reactions are extremely rare at less than 1 per 2.5 million injections historically. The 30-minute post-injection observation period exists specifically to identify and treat any systemic response before it progresses. Patients with uncontrolled or severe asthma face the highest risk and should not receive SCIT injections when asthma is poorly controlled.
When to Worry: Decision Guide
Is the reaction limited to redness and swelling at the injection site only?
Local reaction
Apply ice, take OTC antihistamine, report size to allergist at next visit. Continue treatment.
Possible systemic reaction
Use your prescribed epinephrine auto-injector if symptoms are systemic, call 911, and notify your care team immediately.
Do you have hives, throat tightness, wheezing, or difficulty breathing?
Systemic/anaphylactic reaction
Use your prescribed epinephrine auto-injector and call 911 immediately, then notify your care team — on a Zoom-supervised dose your allergist directs treatment live.
Mild systemic symptom
Notify your care team and stay monitored with your epinephrine within reach until symptoms fully resolve; use the auto-injector and call 911 if they progress.
Frequently asked questions
How long does it take for allergy shots to start working?
Most patients notice some symptom improvement within 3 to 6 months of starting allergy shots, typically near the end of the build-up phase when doses approach the maintenance level. However, the most significant clinical improvements — and the disease-modifying effects that persist after treatment ends — generally require 12 to 18 months of consistent treatment. A 2018 cohort study by Lee et al. (Allergy Asthma Immunol Res) found that treatment duration of at least 3 years was the strongest single predictor of clinical remission, with an odds ratio of 7.37. If you are not noticing any improvement after 12 months of maintenance dosing, your allergist should reassess allergen selection and dosing before deciding whether to discontinue.
What percentage of patients respond to allergy shots?
Approximately 50 to 80 percent of patients achieve clinically meaningful symptom improvement with allergy shots, based on AAAAI Practice Parameters and multiple systematic reviews. A Beijing HDM cohort study (Li et al., 2019) found 57.4% of patients were classified as high responders versus 42.6% low or non-responders at the 3-year mark. These figures are for patients who remain on treatment for an adequate duration — the real-world completion rate is much lower, with only about 18% of patients reaching the recommended 3-year minimum (Kiel et al., Ann Allergy Asthma Immunol 2013). The 20-50% non-response rate is largely attributable to inadequate duration, suboptimal allergen selection, or subtherapeutic dosing, rather than a fundamental failure of the immunotherapy mechanism.
Do allergy shots work for everyone?
No — allergy shots are not universally effective. They work best for patients with IgE-mediated allergic rhinitis, allergic conjunctivitis, or allergic asthma caused by well-characterized allergens like grass pollen, dust mites, ragweed, or cat dander. Evidence is moderate for birch and Alternaria mold. Evidence for cockroach SCIT is weak — the most rigorous modern trial (CRITICAL 2024, Zoratti et al., JACI) failed its primary clinical endpoint entirely. Dog SCIT has weaker evidence than cat. Predictors of better response include monosensitization, younger age, shorter allergy duration, and high baseline specific IgE. Food allergies, non-allergic asthma, and eczema without clear IgE triggers are generally not responsive to SCIT. A board-certified allergist can assess your specific profile before starting.
How long do allergy shot benefits last after stopping?
Research consistently shows that allergy shot benefits persist for years — not just months — after completing a full course of treatment. The landmark Durham et al. (N Engl J Med 1999) study found that patients who completed 3-4 years of grass SCIT maintained symptom and medication scores as low as those who continued maintenance shots for at least 3 years after stopping. Longer follow-up data from Eng et al. (Allergy 2006) found statistically significant clinical benefits persisting 12 years after treatment in pediatric patients. The EAACI recommends a minimum of 3 years of treatment specifically because shorter courses — even 2 years — do not produce this durable post-treatment benefit, as demonstrated by the GRASS trial (Scadding et al., JAMA 2017).
Can allergy shots prevent asthma?
Evidence from the PAT (Prevention of Allergy Treatment) study suggests allergy shots can reduce the risk of children with hay fever developing asthma. Jacobsen et al. (Allergy 2007) found an odds ratio of 2.5 favoring SCIT for asthma prevention in children 7 years after treatment ended. However, this trial was open-label and not blinded. The comparable grass SLIT GAP trial (Valovirta et al., JACI 2018) failed its primary endpoint of preventing spirometric asthma diagnosis, though it showed reduced asthma symptoms and medication use. SCIT is also established for reducing asthma symptoms and medication use in patients who already have allergic asthma — the Abramson Cochrane review (2010, 88 trials) found a number-needed-to-treat of 3 to prevent one deterioration in asthma symptoms. SCIT should only be administered when asthma is well-controlled; injections are withheld when FEV1 falls below 70% predicted.
Are allergy shots worth it if I have mild allergies?
For mild seasonal allergies controlled adequately with an over-the-counter antihistamine and nasal spray, allergy shots may not be the most practical choice. The treatment requires 60-100+ clinic visits over 3-5 years and carries a small but real systemic reaction risk. For patients with moderate-to-severe symptoms, multiple allergen triggers, or those for whom medications provide inadequate relief, the cost-benefit calculation favors SCIT — particularly when accounting for the disease-modifying durability (7-12 years of sustained benefit per Eng et al. data) and asthma prevention in children. A board-certified allergist can help weigh your specific symptom burden, allergy panel results, and lifestyle factors to determine whether immunotherapy is justified.
Why don't allergy shots work for some people?
The most common reasons allergy shots fail in clinical practice are inadequate treatment duration, subtherapeutic dosing, and incorrect allergen selection — not a fundamental failure of the underlying immune mechanism. Studies show that patients who stop early (before 3 years) account for most of the non-response rate in real-world data. The AAAAI/ACAAI Practice Parameter states that at least one year of maintenance dosing is required before declaring treatment ineffective. Other factors include polysensitization where the targeted allergens miss the patient's most clinically relevant triggers, and missed injections that require dose reductions and restart protocols. If you have not responded to allergy shots, your allergist should review allergen selection, dosing history, and treatment duration before considering discontinuation.
Do allergy shots work for both children and adults?
Yes, allergy shots are effective across age groups, though the evidence base differs slightly. Adult data from the Calderon Cochrane review (2007) showed larger effect sizes (SMD -0.56 adults vs -0.25 pediatric per Dhami et al., Allergy 2017). For children, the PAT study and multiple pediatric meta-analyses confirm meaningful symptom and medication reduction, and the additional benefit of asthma prevention is most relevant in children. SCIT is generally not started in children under 5 years due to difficulty communicating symptoms of early systemic reactions. Older patients (over 65) can also benefit, though systemic reaction risk increases with uncontrolled comorbid conditions like cardiovascular disease or severe asthma. An allergist will assess suitability based on individual health status regardless of age.
Related Articles
Allergy Immunotherapy Success Rate: Evidence & Data | Curex
Allergy immunotherapy success rate: SCIT achieves SMD −0.73 symptom reduction; 76.6% HDM remission at 5 years. Compare SCIT vs SLIT by allergen.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Shots for Cat Allergy | Full SCIT Guide | Curex
Allergy shots for cat allergies reduce symptoms 60-72% at the 15 mcg Fel d 1 maintenance dose. Cat SCIT efficacy, dosing, and alternatives.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreLong-Term Side Effects of Allergy Shots | Safety | Curex
Long-term side effects of allergy shots: aluminum exposure, organ safety, fatigue, and post-treatment durability reviewed with real surveillance data.
Read moreAllergy Shots: Complete SCIT Guide for Patients | Curex
Allergy shots (SCIT) reduce symptoms by 33-85% over 3-5 years. Learn how they work, what they cost, and who qualifies for this disease-modifying treatment.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.